Blog Layout

Stanford Medicine’s 2020 Health Trends Report spotlights the rise of the data-driven physician

The report documents key trends steering the industry’s future, including a maturing digital health market, new health laws opening patient access to data, and artificial intelligence gaining regulatory traction for medical use.

In a health care sector now awash with data and digital technologies, physicians are actively preparing for the transformation of patient care, according to the 2020 Health Trends Report published by Stanford Medicine.

 

Stanford Medicine’s 2020 Health Trends Report once again documents key trends steering the industry’s future, including a maturing digital health market, new health laws opening patient access to data, and artificial intelligence gaining regulatory traction for medical use. 

To understand how these trends will reach the doctor’s office and ultimately shape patient care, Stanford Medicine commissioned a national survey of more than 700 physicians, residents, and medical students. As a proxy for the health care delivery system writ large, these individuals were polled for their thoughts about the future of medical practice and how they are preparing for it. 


“We found that current and future physicians are not only open to new technologies but are actively seeking training in subjects such as data science to enhance care for their patients,” said Lloyd Minor, MD, dean of the Stanford University School of Medicine. “We are encouraged by these findings and the opportunity they present to improve patient outcomes. At the same time, we must be clear-eyed about the challenges that may stymie progress.”


The survey’s findings have major implications for patients, their future experiences of health care, and the services to which they will have access in the next decade.


Key Findings


1. Health care providers adapting to new developments 

·      Physicians, residents, and students expect that almost a third of their duties could be automated by technology in the next 20 years.

·      Nearly half of all physicians (47%) and three quarters of medical students (73%) are currently seeking out additional training to better prepare themselves for innovations in health care. These pursuits gravitate toward data-oriented subjects such as advanced statistics, genetic counseling, population health, and coding. 

·      Among physicians who are seeking additional training, 34% are pursuing classes in artificial intelligence.

2. Health care providers are digital health users and see clinical value in patient-generated sources of health data 

·      Nearly half of all physicians, students, and residents use a wearable health monitoring device. Among those who wear them, a majority say they use the data to inform their personal health care decisions (71% of physicians, 60% of students and residents).

·      A majority of students and residents (78%) and physicians (80%) say that self-reported data from a patient’s health app would be clinically valuable in supporting their care. 

·      The group also sees clinical value in data received from sources such as a patient wearable device (79% students and residents; 83% physicians) and data from consumer genetic testing reports (63% students and residents, 65% physicians).

3. A transformation gap: survey responses among current and future physicians reveal significant gaps in readiness to implement emerging technologies

·      There are large gaps in readiness for some of the most critical new health care developments such as telemedicine, personalized medicine, and genetic screening. 

·      When asked to rate the effectiveness of their education to prepare them for these developments, only 18% of current medical students and residents surveyed said that their education was “very helpful,” while 44% of physicians surveyed said that their education was either “not very helpful” or “not helpful at all.” 

·      This gap can be closed by modernizing the appropriate curriculum and training programs so that both current and future physicians can effectively use and make the most of new technologies. 

4. Under pressure

·      Physicians and those in training are struggling under medical practice burdens. 

·      Among physicians and residents surveyed, nearly one in five would change their career path if they were given the opportunity to do so, citing poor work-life balance and administrative burdens as the top reasons for reconsidering a medical career.


The rise of the data-driven physician represents an opportunity to positively transform medicine and improve health outcomes by bringing new technologies and insights to the patient bedside. However, as it stands today, medical professionals still feel insufficiently trained to do so. Moreover, promising medical talent is being held back by challenges such as achieving work-life balance and student debt.

As a new decade gets underway, Stanford Medicine’s 2020 Health Trends Report offers insights for health educators, employers, government officials, and private industry to take action and help tomorrow’s health care workforce reach its full potential.


Methodology: In addition to conducting a secondary review of news articles, white papers and peer-review research for the 2020 Health Trends Report, Stanford Medicine worked with Brunswick Insight to conduct a comprehensive survey of 523 current physicians and 210 medical students and residents. Respondents were contacted between September and October of 2019. Respondents were contacted through a list of American Medical Association-verified physicians and survey-sample panels of medical professionals. Respondents were compensated for their involvement in the survey and were informed that their responses would be used to inform public-facing research. Respondents were given the opportunity to opt out of any and all questions in the survey.


Media Contacts

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.


Share this Article with others

08 Mar, 2024
The aims of our case-control study were (1) to develop an automated 3-dimensional (3D) Convolutional Neural Network (CNN) for detection of pancreatic ductal adenocarcinoma (PDA) on diagnostic computed tomography scans (CTs), (2) evaluate its generalizability on multi-institutional public data sets, (3) its utility as a potential screening tool using a simulated cohort with high pretest probability, and (4) its ability to detect visually occult preinvasive cancer on prediagnostic CTs.
08 Mar, 2024
Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress
08 Mar, 2024
International cancer registries make real-world genomic and clinical data available, but their joint analysis remains a challenge. AACR Project GENIE, an international cancer registry collecting data from 19 cancer centers, makes data from >130,000 patients publicly available through the cBioPortal for Cancer Genomics (https://genie.cbioportal.org). For 25,000 patients, additional real-world longitudinal clinical data, including treatment and outcome data, are being collected by the AACR Project GENIE Biopharma Collaborative using the PRISSMM data curation model. Several thousand of these cases are now also available in cBioPortal. We have significantly enhanced the functionalities of cBioPortal to support the visualization and analysis of this rich clinico-genomic linked dataset, as well as datasets generated by other centers and consortia. Examples of these enhancements include (i) visualization of the longitudinal clinical and genomic data at the patient level, including timelines for diagnoses, treatments, and outcomes; (ii) the ability to select samples based on treatment status, facilitating a comparison of molecular and clinical attributes between samples before and after a specific treatment; and (iii) survival analysis estimates based on individual treatment regimens received. Together, these features provide cBioPortal users with a toolkit to interactively investigate complex clinico-genomic data to generate hypotheses and make discoveries about the impact of specific genomic variants on prognosis and therapeutic sensitivities in cancer.
08 Mar, 2024
The majority of disease-associated variants identified through genome-wide association studies are located outside of protein-coding regions. Prioritizing candidate regulatory variants and gene targets to identify potential biological mechanisms for further functional experiments can be challenging. To address this challenge, we developed FORGEdb, a standalone and web-based tool that integrates multiple datasets, delivering information on associated regulatory elements, transcription factor binding sites, and target genes for over 37 million variants. FORGEdb scores provide researchers with a quantitative assessment of the relative importance of each variant for targeted functional experiments.
By Bo Zhang 08 Mar, 2024
Cancer is a leading cause of morbidity and mortality worldwide. While progress has been made in the diagnosis, prognosis, and treatment of cancer patients, individualized and data-driven care remains a challenge. Artificial intelligence (AI), which is used to predict and automate many cancers, has emerged as a promising option for improving healthcare accuracy and patient outcomes. AI applications in oncology include risk assessment, early diagnosis, patient prognosis estimation, and treatment selection based on deep knowledge. Machine learning (ML), a subset of AI that enables computers to learn from training data, has been highly effective at predicting various types of cancer, including breast, brain, lung, liver, and prostate cancer. In fact, AI and ML have demonstrated greater accuracy in predicting cancer than clinicians. These technologies also have the potential to improve the diagnosis, prognosis, and quality of life of patients with various illnesses, not just cancer. Therefore, it is important to improve current AI and ML technologies and to develop new programs to benefit patients. This article examines the use of AI and ML algorithms in cancer prediction, including their current applications, limitations, and future prospects. Lead Author: Bo Zhang
By Claudio Luchini 08 Mar, 2024
Artificial intelligence (AI) is concretely reshaping the landscape and horizons of oncology, opening new important opportunities for improving the management of cancer patients. Analysing the AI-based devices that have already obtained the official approval by the Federal Drug Administration (FDA), here we show that cancer diagnostics is the oncology-related area in which AI is already entered with the largest impact into clinical practice. Furthermore, breast, lung and prostate cancers represent the specific cancer types that now are experiencing more advantages from AI-based devices. The future perspectives of AI in oncology are discussed: the creation of multidisciplinary platforms, the comprehension of the importance of all neoplasms, including rare tumours and the continuous support for guaranteeing its growth represent in this time the most important challenges for finalising the ‘AI-revolution’ in oncology. First Author: Claudio Luchini,
By Panayiotis Petousis, PhD 08 Mar, 2024
In the United States, end-stage kidney disease (ESKD) is responsible for high mortality and significant healthcare costs, with the number of cases sharply increasing in the past 2 decades. In this study, we aimed to reduce these impacts by developing an ESKD model for predicting its occurrence in a 2-year period.  Lead Author: Panayiotis Petousis, PhD
By Evan D. Muse 08 Mar, 2024
Transforming the cardiometabolic disease landscape: Multimodal AI-powered approaches in prevention and management Lead Author: Evan D. Muse
By Danielle S. Bitterman, MD 08 Mar, 2024
Current status and future applications of LLMs for cancer symptom management and call for cross-disciplinary collaboration that centers the needs of patients and caregivers L ead Author: Danielle S. Bitterman, MD
01 Mar, 2023
New computer systems aim to peer inside our heads—and to help us fix what they find there In the nineteen-sixties, Joseph Weizenbaum, a computer scientist at M.I.T., created a computer program called Eliza. It was designed to simulate Rogerian therapy, in which the patient directs the conversation and the therapist often repeats her language back to her: U ser : My boyfriend made me come here. E liza : Your boyfriend made you come here. U ser : He says I’m depressed much of the time. E liza : I am sorry to hear you are depressed. U ser : It’s true. I am unhappy. E liza : Do you think coming here will help you not to be unhappy? Weizenbaum made Eliza as satire. He doubted that computers could simulate meaningful human interaction. He was alarmed, therefore, when many people who tried the program found it both useful and captivating. His own secretary asked him to leave the room so that she could spend time alone with Eliza. Worse, doctors saw it as a potentially transformative tool. “Several hundred patients an hour could be handled by a computer system designed for this purpose,” three psychiatrists wrote in The Journal of Nervous and Mental Disease, in 1966. “The human therapist, involved in the design and operation of this system, would not be replaced, but would become a much more efficient man since his efforts would no longer be limited to the one-to-one patient-therapist ratio as now exists.” Weizenbaum became an outspoken critic of artificial intelligence. “But the genie was out of the bottle,” Brian Christian, who chronicled the episode in his book “The Most Human Human,” told me. A few years later, a Stanford psychiatrist named Kenneth Colby created Parry, a program that attempted to simulate the language of a person with paranoid schizophrenia, to train students before they cared for real patients. Psychiatrists given transcripts of therapy sessions often couldn’t tell the difference between Parry and humans; in this narrow sense, the chatbot passed the Turing test. In 1972, Parry and Eliza met up for a therapy session: P arry : Do you know anything about bookies? E liza : What makes you think I know anything about bookies? P arry : A bookie didn’t pay me off once. E liza : What does that suggest to you? P arry : I beat up the bookie who did not pay off, and I thought he might use his friends in the underworld to get even with me.  Over time, programmers developed Jabberwacky, Dr. Sbaitso, and alice (the Artificial Linguistic Internet Computer Entity). Exchanges with these chatbots were often engaging, sometimes comical, and occasionally nonsensical. But the idea that computers could serve as human confidants, expanding therapy’s reach beyond the limits of its overworked practitioners, persisted through the decades. In 2017, Alison Darcy, a clinical research psychologist at Stanford, founded Woebot, a company that provides automated mental-health support through a smartphone app. Its approach is based on cognitive behavioral therapy, or C.B.T.—a treatment that aims to change patterns in people’s thinking. The app uses a form of artificial intelligence called natural language processing to interpret what users say, guiding them through sequences of pre-written responses that spur them to consider how their minds could work differently. When Darcy was in graduate school, she treated dozens of hospitalized patients using C.B.T.; many experienced striking improvements but relapsed after they left the hospital. C.B.T. is “best done in small quantities over and over and over again,” she told me. In the analog world, that sort of consistent, ongoing care is hard to find: more than half of U.S. counties don’t have a single psychiatrist, and, last year, a survey conducted by the American Psychological Association found that sixty per cent of mental-health practitioners don’t have openings for new patients. “No therapist can be there with you all day, every day,” Darcy said. Although the company employs only about a hundred people, it has counseled nearly a million and a half, the majority of whom live in areas with a shortage of mental-health providers. Link to original article on The New Yorker
Share by: